Religion row: Decision on expert panel deferred

Bengaluru, May 28: As many as 115 new coronavirus cases were reported in Karnataka on Thursday taking the infection count to 2,533, Karnataka Minister S Suresh said.

The total coronavirus cases include 834 discharges, 1,650 active cases, 47 deaths so far due to the disease and two deaths due non-COVID causes, Suresh Kumar, who is minister for primary and secondary education, said during the daily COVID-19 briefing.

According to him, 29 cases were reported in Udupi on Thursday, followed by 24 in Dakshina Kannada district, 13 in Hassan, 12 in Bidar, nine in Bengaluru Urban, seven in Yadagiri, six in Chitradurga, five in Kalaburagi, four in Haveri, three in Chikkamagaluru, two in Vijayapura and one in Raichur.

The minister said among the new cases, 95 are inter-state passengers and two international passengers.

According to the health department, 84 infected people have returned from Maharashtra and eight from Tamil Nadu.

Among those discharged today, 13 are in Davangere, 12 in Dakshina Kannada, nine each in Yadagiri and Vijayapura, five in Gadag, three in Belagavi, one each in Mysuru and Bagalkote.

Two are severe acute respiratory infection cases.

There were, however, no coronavirus related deaths in the state today, the minister said.

Kumar said the government has issued another circular making changes in the quarantine rules.

"A person who has completed seven days of institutional quarantine and is asymptomatic can be permitted for home quarantine without a COVID test, subject to undergoing medical check-up," the minister said.

According to the circular, all elderly people of above 60 years of age and those with comorbidities such as diabetes, hypertension, asthma, heart ailment and renal diseases, are required to be clinically evaluated diligently prior to shifting them to home quarantine.

Such people will be under mandatory home quarantine for seven days, the circular read.

Mysuru, Feb 14: Two weeks after her engagement with another boy, a 20-year-old girl who was in love with a boy, committed suicide at her residence in Nanjangud on Wednesday.

Meghana's parents have accused her lover Manikanta of Hemmargala of abetting her suicide. The girl's father in his complaint has claimed that Manikanta threatened to send their photos to her fiance following which she took the extreme step. He has also claimed his daughter was molested by Manikanta two years ago.

Manikanta who is on the run has been booked for rape and abetting suicide following the complaint.

Since the girl was from the SC community, cops have also slapped cases under Atrocities (Prevention) Act against Manikanta. Nanjangud sub-division DSP Prabhkar Rao Shinde will investigate the case as charges have been made under provisions of the act.

University of Oxford researchers have claimed that a cheap and widely available drug called dexamethasone can help save the lives of patients who are seriously ill with coronavirus.

Scientists working on the Recovery Trial found the drug could help patients on ventilators and oxygen, but had no effect on those who did not need help breathing.

“Based on these results, one death would be prevented by treatment of around eight ventilated patients or around 25 patients requiring oxygen alone,” researchers said in a statement.

Matt Hancock, the health secretary, tweeted: “This global first exemplifies the power of science.”

“I’m absolutely delighted that today we can announce the first successful clinical trial for a treatment for Covid-19,” Mr Hancock said.

Recovery Trial experts said a randomised group of 2,104 patients was given 6mg of dexamethasone per day for 10 days, while another group of 4,321 were given normal treatment.

Dexamethasone reduced deaths by one-fifth in patients on oxygen feeds and by one-third in those who needed a ventilator to breathe, preliminary results showed.

Mr Hancock added: “This is a huge step forward and it’s because we’ve backed the science.”

Martin Landray, professor of medicine and epidemiology at the Nuffield Department of Population Health, University of Oxford, and one of the trial’s chief investigators, said in a statement: “These preliminary results from the Recovery Trial are very clear – dexamethasone reduces the risk of death among patients with severe respiratory complications.

“Covid-19 is a global disease – it is fantastic that the first treatment demonstrated to reduce mortality is one that is instantly available and affordable worldwide.”